Cuorips (TSE:4894) Research & Development: 円0.0 Mil (TTM As of Mar. 2026)


TSE:4894 Cuorips Inc TSE:4894
69 GF Score
Price 円3,855.00
GF Value 円28,569.75
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Cuorips Research & Development?

Cuorips TSE:4894 -1.15% 69 Research & Development is 円0.0 Mil as of Mar. 2026. GuruFocus rates TSE:4894 with a GF Score™ of 69/100 and a GF Value™ of 円28,569.75 (Possible Value Trap). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cuorips's Research & Development for the six months ended in Mar. 2026 was 円0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0.0 Mil.

Cuorips  (TSE:4894) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cuorips Research & Development Related Terms

Cuorips Research & Development Historical Data

* Premium members only.

The historical data trend for Cuorips's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cuorips Research & Development Chart

Cuorips Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Cuorips Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4894
69GF Score
Cuorips Inc TSE:4894
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cuorips Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0.0 Mil mean?
Cuorips (TSE:4894) has a Research & Development of 円0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Cuorips and its competitors.
Is Cuorips' Research & Development too high?
Cuorips' current Research & Development is 円0.0 Mil. Overall, Cuorips has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cuorips' Research & Development compare to VRTX and REGN?
Cuorips' Research & Development of 円0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cuorips and its competitors. Cuorips's current Research & Development is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cuorips stock overvalued right now?
Based on GuruFocus' analysis, Cuorips (TSE:4894) is currently considered Possible Value Trap. The stock's GF Value™ is 円28,569.75, compared to a current price of 円3,855.00 — trading 86.5% below its estimated fair value. The current Research & Development is 円0.0 Mil. Cuorips' overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cuorips (TSE:4894), the current Research & Development is 円0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cuorips (TSE:4894) Overvalued in 2026?

Based on GuruFocus' analysis, Cuorips stock appears to be undervalued. The current stock price of 円3,855.00 is trading 86.5% below its estimated GF Value™ of 円28,569.75. GuruFocus considers Cuorips to be Possible Value Trap.

Key valuation signals for TSE:4894:

  • Research & Development: 円0.0 Mil
  • GF Value™: 円28,569.75 vs. price of 円3,855.00 (86.5% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the TSE:4894 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cuorips Business Description

Address 3-11-5 Nihonbashi-Honcho, 507, Nihonbashi Life Science Building 2, Chuo-ku, Tokyo, JPN, 103-0023
Cuorips Inc is engaged in the Research, development, manufacturing, and sales of Cellular and Tissue-based Products and Cell processing products. The company is also engaged in Contract development and manufacturing services and consulting services of Cellular and Tissue-based Products and Cell processing product.
69GF Score

Get the complete analysis for TSE:4894

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,855.00
Price
円28,569.75
GF Value